Trial Outcomes & Findings for Corneal Biomechanics and Corneal Reshaping Therapy (NCT NCT02719535)
NCT ID: NCT02719535
Last Updated: 2020-04-13
Results Overview
Corneal Stiffness: in N/mm Corneal parameters usually will stabilize in 1 month, this study will monitor it till 6 months.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
59 participants
Primary outcome timeframe
At baseline, then change from baseline to 6 months
Results posted on
2020-04-13
Participant Flow
Participant milestones
| Measure |
Corneal Reshaping Therapy
Subjects will be wearing corneal reshaping lenses for the correction of their myopia
Corneal reshaping therapy: Reshaping the corneal curvature from wearing specific designed rigid gas permeable lenses
|
|---|---|
|
Overall Study
STARTED
|
59
|
|
Overall Study
COMPLETED
|
37
|
|
Overall Study
NOT COMPLETED
|
22
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Corneal Biomechanics and Corneal Reshaping Therapy
Baseline characteristics by cohort
| Measure |
Corneal Reshaping Therapy
n=37 Participants
Participants receiving Corneal Reshaping Therapy were monitored for ocular biometry and refractive errors throughout a 6-month period. Corneal stiffness and tangent modulus were outcome measures.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
37 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
22 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
30 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
37 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
Hong Kong
|
37 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: At baseline, then change from baseline to 6 monthsCorneal Stiffness: in N/mm Corneal parameters usually will stabilize in 1 month, this study will monitor it till 6 months.
Outcome measures
| Measure |
Treatment
n=37 Participants
Treatment
|
|---|---|
|
Change of Corneal Stiffness From Baseline at 6 Months
|
0.061 N/mm
Standard Deviation 0.007
|
SECONDARY outcome
Timeframe: At baseline, then change from baseline to 6 monthsTangent modulus: in MPa Corneal parameters usually will stabilize in 1 month, this study will monitor it till 6 months.
Outcome measures
| Measure |
Treatment
n=37 Participants
Treatment
|
|---|---|
|
Change of Tangent Modulus From Baseline at 6 Months
|
0.536 MPa
Standard Deviation 0.118
|
Adverse Events
Treatment
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place